Amgen Inc (AMGN)
Healthcare
Drug Manufacturers - General
385.20 $
-0.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Amgen Inc (AMGN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.7% of the shares are freely tradable; institutional investors hold 85.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
85.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.2%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
99.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
2.3%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
540Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 10.16 | 54,838,826 | +1.8 | 12/31/2025 |
| BlackRock Inc | 8.73 | 47,100,472 | -0.6 | 03/31/2026 |
| Vanguard Capital Management, LLC | 6.49 | 35,014,232 | +0.0 | 03/31/2026 |
| State Street Corp | 5.66 | 30,548,488 | -0.1 | 03/31/2026 |
| Capital World Investors | 5.43 | 29,288,343 | +26.8 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 2.93 | 15,836,058 | +0.6 | 03/31/2026 |
| Geode Capital Management, LLC | 2.86 | 15,430,524 | +7.9 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 2.71 | 14,621,148 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.18 | 17,177,234 | +0.3 | 04/30/2026 |
| Vanguard 500 Index Investor | 2.59 | 13,963,088 | +1.8 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.